Page last updated: 2024-09-03

mk 0663 and Hemophilia A

mk 0663 has been researched along with Hemophilia A in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cavanaugh, PF; Matsumoto, AK1
Curtis, SP; Eyster, ME; Giallella, KM; Melian, A; Mukhopadhyay, S; Reicin, AS; Shingo, S; Tsoukas, C1

Reviews

1 review(s) available for mk 0663 and Hemophilia A

ArticleYear
Etoricoxib.
    Drugs of today (Barcelona, Spain : 1998), 2004, Volume: 40, Issue:5

    Topics: Arthritis; Clinical Trials as Topic; Cyclooxygenase 2; Etoricoxib; Hemarthrosis; Hemophilia A; Humans; Isoenzymes; Membrane Proteins; Pain; Prostaglandin-Endoperoxide Synthases; Pyridines; Spondylitis, Ankylosing; Sulfones

2004

Trials

1 trial(s) available for mk 0663 and Hemophilia A

ArticleYear
Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy.
    Blood, 2006, Mar-01, Volume: 107, Issue:5

    Topics: Adolescent; Adult; Aged; Child; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Headache; Hemarthrosis; Hemophilia A; Humans; Lactones; Male; Membrane Proteins; Middle Aged; Pyridines; Respiratory Tract Infections; Sulfones; Treatment Outcome

2006